|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,551.50 DKK | 0.00% |
|
+1.61% | -28.05% |
| Dec. 04 | Scancell Signs New Commercial License Deal With Genmab | MT |
| Dec. 04 | Scancell Holdings plc Announces Genmab Exercises Option to A Second Commercial License Agreement | CI |
| Capitalization | 103B 14.56B 13.77B 12.8B 11.41B 20.42B 1,233B 22.61B 158B 58.73B 505B 54.64B 53.47B 2,186B | P/E ratio 2024 * |
18.7x | P/E ratio 2025 * | 16.8x |
|---|---|---|---|---|---|
| Enterprise value | 85.71B 12.15B 11.5B 10.68B 9.53B 17.05B 1,029B 18.87B 132B 49.02B 422B 45.6B 44.63B 1,824B | EV / Sales 2024 * |
4.05x | EV / Sales 2025 * | 3.13x |
| Free-Float |
95.95% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Genmab A/S
More recommendations
More press releases
More news
| 1 day | +1.50% | ||
| 1 week | +2.68% | ||
| Current month | +1.67% | ||
| 1 month | +2.21% | ||
| 3 months | -16.81% | ||
| 6 months | -19.92% | ||
| Current year | -28.00% |
1 week
1 523.50
1 567.00
1 month
1 431.001 652.00
Current year
1 431.002 227.00
1 year
1 431.002 283.00
3 years
1 431.003 327.00
5 years
1 082.503 327.00
10 years
308.003 327.00
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2010-05-31 | |
Anthony Pagano
DFI | Director of Finance/CFO | 46 | 2020-02-29 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 2024-08-15 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 73 | 2003-10-31 | |
| Director/Board Member | 57 | 2014-12-31 | |
| Director/Board Member | 73 | 2014-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.64% | 203 M€ | +13.92% | ||
| 1.01% | 83 M€ | +20.35% | ||
| 0.75% | 20 M€ | +16.75% | - | |
| 0.56% | 772 M€ | +17.58% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +1.50% | +2.68% | -29.38% | -36.85% | 14.56B | ||
| -0.88% | -1.00% | +29.87% | +125.66% | 118B | ||
| +1.81% | +1.73% | -6.46% | +20.90% | 82.62B | ||
| +0.37% | +0.20% | +38.03% | +132.61% | 37.77B | ||
| +3.61% | -1.56% | +20.36% | -65.46% | 28.49B | ||
| +1.29% | -2.18% | +9.51% | -35.81% | 21.43B | ||
| -0.14% | +4.07% | -31.18% | -63.74% | 20.2B | ||
| -0.04% | -0.72% | +174.13% | +190.96% | 13.48B | ||
| -0.45% | -7.50% | +612.20% | +250.40% | 12.92B | ||
| -1.03% | -0.13% | +6.65% | +58.66% | 12.8B | ||
| Average | +0.41% | -0.78% | +82.37% | +57.73% | 36.27B | |
| Weighted average by Cap. | +0.08% | -0.63% | +40.00% | +65.41% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 21.18B 3B 2.84B 2.64B 2.35B 4.21B 254B 4.66B 32.65B 12.11B 104B 11.27B 11.03B 451B | 24.76B 3.51B 3.32B 3.09B 2.75B 4.92B 297B 5.45B 38.16B 14.16B 122B 13.17B 12.89B 527B |
| Net income | 5.48B 776M 734M 682M 608M 1.09B 65.75B 1.21B 8.44B 3.13B 26.94B 2.91B 2.85B 117B | 6.24B 885M 837M 778M 694M 1.24B 74.98B 1.37B 9.62B 3.57B 30.71B 3.32B 3.25B 133B |
| Net Debt | -16.98B -2.41B -2.28B -2.12B -1.89B -3.38B -204B -3.74B -26.17B -9.71B -83.51B -9.03B -8.84B -361B | -25.25B -3.58B -3.39B -3.15B -2.81B -5.02B -303B -5.56B -38.93B -14.44B -124B -13.44B -13.15B -537B |
More financial data
* Estimated data
Employees
2,635
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-06 | 1,550.50 kr | -0.06% | 4,218 |
| 24-12-05 | 1,551.50 kr | +1.50% | 77,833 |
| 24-12-04 | 1,528.50 kr | -0.20% | 98,222 |
| 24-12-03 | 1,531.50 kr | -1.29% | 82,092 |
| 24-12-02 | 1,551.50 kr | +1.67% | 107,473 |
Delayed Quote Nasdaq Copenhagen, December 05, 2024 at 11:20 am EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
1,551.50DKK
Average target price
2,345.00DKK
Spread / Average Target
+51.14%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GMAB Stock